Curigin Inc logo
VerifiedBiotechnology Research

Curigin Inc

At Curigin, we are developing innovative therapies using our novel bi-specific shRNA technology to simultaneously knockdown two different disease causing pathways. Our lead pipelines target cancer pathways such as mTOR and STAT3 and deliver our bi-specific shRNA through an oncolytic virus genetically engineered to exclusively target and replicate in cancer cells.

7-day free trial · no credit card

HeadquartersSeoul, South KoreaEmployees7(11 to 50)Websitecurigin.comLinkedIn profileLinkedIn

Verified contacts

6

available on Kipplo

LinkedIn employees

7

11 to 50 range

Open roles

no listings

Distinct roles

6

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 6 verified contacts at Curigin Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

6 contacts with verified email or phone · masked until revealed.

Sign up free →

No verified contacts on record for this company yet.

Top roles at Curigin Inc

6 distinct titles indexed · top 6 shown.

  • 1(주)큐리진
  • 1bioinformatics engineer
  • 1pharmacology and toxicology team lead
  • 1president
  • 1team leader business development team
  • 1사업 개발 관리자

Sign up to unlock all 6 contacts at Curigin Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 6 verified contacts at Curigin Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Curigin Inc | Kipplo Discover